Find a Supplier
Add Company
HAPILA reaching completion of design for new GMP production plant for APIs
Contact Us Subscribe to Newsletter
Subscribe to Supplier

Subscribe to Supplier

.
HAPILA reaching completion of design for new GMP production plant for APIs

HAPILA GmbH News Releases

Find the latest News from HAPILA GmbH

Page 1 of 2
HAPILA reaching completion of design for new GMP production plant for APIs
HAPILA reaching completion of design for new GMP production plant for APIs

Thursday 26th August 2021

By  HAPILA GmbH Learn More >
HAPILA extends analytical gas chromatography capabilities
HAPILA extends analytical gas chromatography capabilities

Thursday 27th May 2021

By  HAPILA GmbH Learn More >
HAPILA extends production capacity by installation of a pilot plant for BTZ043 anti-TB agent
HAPILA extends production capacity by installation of a pilot plant for BTZ043 anti-TB agent

Thursday 8th April 2021

By  HAPILA GmbH Learn More >
Authorities extend CEP certification for HAPILA’s Estriol estrogen API
Authorities extend CEP certification for HAPILA’s Estriol estrogen API

Tuesday 2nd March 2021

By  HAPILA GmbH Learn More >
HAPILA becomes a teenager
HAPILA becomes a teenager

Tuesday 2nd June 2020

By  HAPILA GmbH Learn More >
HAPILA commits to rescheduled Chemspec Europe Exhibition
HAPILA commits to rescheduled Chemspec Europe Exhibition

Tuesday 12th May 2020

By  HAPILA GmbH Learn More >
HAPILA extends commitment to ‘green’ energy
HAPILA extends commitment to ‘green’ energy

Monday 23rd March 2020

By  HAPILA GmbH Learn More >
HAPILA’s BTZ-043 anti TB agent commences human trials
HAPILA’s BTZ-043 anti TB agent commences human trials

Thursday 9th January 2020

By  HAPILA GmbH Learn More >
HAPILA showcases advanced API development expertise at CPhI Worldwide Frankfurt
HAPILA showcases advanced API development expertise at CPhI Worldwide Frankfurt

Wednesday 23rd October 2019

By  HAPILA GmbH Learn More >
HAPILA gains ISO certification and FDA approval
HAPILA gains ISO certification and FDA approval

Friday 4th October 2019

By  HAPILA GmbH Learn More >
HAPILA anti-TB agent BTZ043 wins Germany’s IQ Innovation Award
HAPILA anti-TB agent BTZ043 wins Germany’s IQ Innovation Award

Friday 9th August 2019

By  HAPILA GmbH Learn More >
Anti-TB substance BTZ-043 passes Clinical Trial Phase Ia milestone
Anti-TB substance BTZ-043 passes Clinical Trial Phase Ia milestone

Wednesday 17th July 2019

By  HAPILA GmbH Learn More >
Page 1 of 2